Study Finds PSA Testing Cuts Prostate Cancer Death Risk

WEDNESDAY, March 14 (HealthDay News) — Adding another perspective to one of the most controversial and confounding issues in medicine, a new European study reports that men who received routine prostate-specific antigen (PSA) tests to check for signs of prostate cancer were 30 percent less likely to die from the disease.